AQR Capital Management’s Adamas Pharmaceuticals, Inc. ADMS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2020
Q3 | – | Sell |
-420,304
| Closed | -$1.08M | – | 2304 |
|
|
2020
Q2 | $1.08M | Buy |
420,304
+203,582
| +94% | +$521K | ﹤0.01% | 1431 |
|
|
2020
Q1 | $626K | Buy |
216,722
+169,014
| +354% | +$488K | ﹤0.01% | 1502 |
|
|
2019
Q4 | $181K | Buy |
+47,708
| New | +$181K | ﹤0.01% | 2022 |
|
|
2018
Q4 | – | Sell |
-14,897
| Closed | -$298K | – | 2317 |
|
|
2018
Q3 | $298K | Sell |
14,897
-917
| -6% | -$18.3K | ﹤0.01% | 2110 |
|
|
2018
Q2 | $408K | Buy |
15,814
+3,310
| +26% | +$85.4K | ﹤0.01% | 2046 |
|
|
2018
Q1 | $299K | Buy |
12,504
+3,329
| +36% | +$79.6K | ﹤0.01% | 2048 |
|
|
2017
Q4 | $311K | Buy |
+9,175
| New | +$311K | ﹤0.01% | 2059 |
|
|
2016
Q1 | – | Sell |
-9,964
| Closed | -$282K | – | 2311 |
|
|
2015
Q4 | $282K | Buy |
+9,964
| New | +$282K | ﹤0.01% | 2054 |
|